On February 13, 2019, the Missouri Department of Health and Senior Services (DHSS) held a forum to receive suggestions regarding the drafting of preliminary regulations governing medical cannabis in Missouri. Medical cannabis was legalized in Missouri in November by a constitutional amendment approved by Missouri voters, known as Amendment 2.
The standing-room-only forum in Jefferson City included potential medical cannabis business owners and advisors, as well as potential medical cannabis patients, cultivators, and Missouri legislators. DHSS encouraged audience members to provide ideas that DHSS could consider when drafting proposed regulations governing medical cannabis. DHSS indicated that proposed rules will be released on an ongoing basis, with final rules to be released at the same time the formal application process begins.
Suggestions covered a wide range of topics related to medical cannabis in Missouri, including the relative weight that DHSS should give to each licensing criteria specified by Amendment 2, quality control and testing, fees and profits, startup logistics, and distribution issues.
Licensing
A number of audience members believed that the licensing requirements imposed by Amendment 2 are overly complicated and onerous for small business owners. They suggested that DHSS impose a page limit for medical cannabis business license applications to simplify the application process.
A large portion of the audience expressed strong concerns about out-of-state cannabis businesses. They suggested that DHSS give greater weight to businesses that can show that they are wholly owned by Missouri citizens or for DHSS to examine applicant capitalization to ensure that applicants are funded by Missourians. Another major concern was keeping profits on Missouri medical cannabis in Missouri communities. Audience members suggested that DHSS give greater weight, when considering license applications, to medical cannabis business applicants that include a community outreach or reinvestment focus in their business plans.
Quality control and testing
The audience expressed general dismay at the low number of medical cannabis testing facilities allowed by Amendment 2. Many suggested that DHSS implement specific testing protocols that facilities must follow to lend predictability to the testing process. To protect the integrity of the testing system, other audience members suggested that testing facilities should collect samples at random, rather than allow medical cannabis facilities to select their own samples to be tested.
Audience members disagreed as to the manufacturing standards that should govern infused product manufacturing facilities; some argued that DHSS should specify its own protocols, while others advocated that the DHSS should require compliance with good manufacturing protocols and Global Food Safety Initiative standards.
Fees and cannabis business profits
Many audience members were concerned the licensing fees for medical cannabis businesses are too high and will be a significant barrier to entry into the Missouri medical cannabis market. Another significant concern was the affordability of medical cannabis, especially if health insurance companies will not cover a medical cannabis patient’s costs. Audience members suggested giving cannabis businesses incentives (such as reduced license renewal or annual fees) to provide discounts to indigent patients and to veterans.
Start-up logistics
The issue of sourcing seeds or mother plants to help cultivators get their initial crops underway was also discussed. Suggested solutions varied between immunizing cultivators who import medical cannabis seeds and strains from out-of-state from penalties under Missouri law to fast-tracking cultivator licenses, providing them more time to source seeds and clones for their initial crops.
Small business owners in the audience noted that they likely would not utilize the entire 30,000 indoor square feet they may be authorized to use for cultivation if their applications were approved. Some suggested that they be allowed to allocate their approved cultivation space between outdoor and indoor cultivation areas, up to the 30,000 square foot cap.
Attendees also suggested relaxing certification requirements for “ancillary” medical cannabis workers who secure, transport, trim, or dispose of medical cannabis waste to make it easier for smaller businesses to contract with or hire such workers to aid in their operations. One audience member asked if DHSS will provide a mechanism by which a medical cannabis facility could re-locate its operations under the same license.
Distribution issues
Audience members overwhelmingly agreed that ensuring access to disabled and remote patients is extremely important. One of the most common suggestions of the entire forum was that DHSS provide for a medical cannabis delivery system for disabled and remote patients. Along the same line, many audience members expressed dismay at the possibility that municipalities hostile toward medical cannabis will attempt to circumvent constitutional mandates for patient access to medical cannabis. Such audience members suggested that DHSS prevent municipalities from relegating medical cannabis businesses to the outskirts of town by zoning medical cannabis uses as “industrial.”
Another major concern was the amount of packaging that medical cannabis dispensaries would be required to use if DHSS requires every medical cannabis product to be packaged separately. Audience members suggested that DHSS endorse “exit packaging” whereby dispensaries would be required to ensure that all products sold to a given patient were sealed in a single child-proof package when the patient leaves the dispensary. According to audience members, exit packaging would significantly reduce the amount of packaging that dispensaries use, resulting in cost savings and a reduced environmental impact.
At the end of the forum DHSS thanked the audience for their comments and suggestions and indicated that it would release proposed regulations on a rolling basis as they are drafted. Missourians will have an opportunity to comment on such proposed regulations before they are finalized on June 4, 2019.